| Patent Number |
Title Of Patent |
Date Issued |
| 5833886 |
Thermostability enhancement of polyphosphate flame retardants |
November 10, 1998 |
| The thermostability of an aromatic polyphosphate composition an be improved by the addition of an effective amount of a hydroxy-terminated aromatic polyphosphate composition for such. |
| 5831109 |
Polyalkylaluminoxane compositions formed by non-hydrolytic means |
November 3, 1998 |
| The present invention relates to a process which comprises the non-hydrolytic transformation of an aluminoxane precursor composition, comprising carbon-to-oxygen bonds which can be alkylated by an alkylaluminum moiety, into a catalytically useful aluminoxane composition. In one embod |
| 5830681 |
Immunoassays for and monoclonal antibodies to prothrombin activation peptide F1.2 |
November 3, 1998 |
| Monoclonal antibodies and fragments thereof, with binding specificity for an epitope on the carboxy terminus of prothrombin activation peptide F1.2, which can be used in immunoassays to predict thrombosis by measuring the extent of activation of prothrombin. These monoclonal antibodies a |
| 5827646 |
Diagnostic reagents for the detection of antibodies to EBV |
October 27, 1998 |
| The present invention is directed to diagnostic reagents for the detection of antibodies against the Epstein Barr Virus and a method for the detection of antibodies to the Epstein Barr Virus in a sample.The diagnostic reagents according to the invention comprise a combination of at least |
| 5824832 |
Linear alxylbenzene formation using low temperature ionic liquid |
October 20, 1998 |
| A low temperature molten ionic liquid composition comprising a mixture of a metal halide and an alkyl-containing amine hydrohalide salt can be used in linear alkylbenzene formation. The metal halide is a covalently bonded metal halide which can contain a metal selected from the group com |
| 5821317 |
Adduct of bisepoxy compound and P guanamine |
October 13, 1998 |
| The invention pertains to an adduct obtainable by condensation of a bisepoxy compound and a P-guanamine according to the formula ##STR1## wherein X is CR.sub.3 R.sub.4 --(CR.sub.1 R.sub.2).sub.n --CR.sub.5 R.sub.6 or o-phenylidene, n is 0 or 1, and R.sub.1 -R.sub.8 may be the sam |
| 5821305 |
Allyl-containing epoxy resin composition comprising a copolymer of an ethylenically unsaturated |
October 13, 1998 |
| The invention relates to a resin composition comprising epoxy resin, a cross linking agent for the epoxy resin in the form of a carboxylic anhydride, and at least one allyl network forming compound. According to the invention, the anhydride-functional compound is a copolymer of an et |
| 5820806 |
Process for the preparation of polyketone fibers |
October 13, 1998 |
| It has been found that fibres can be spun in a simple manner from polyketone polymer solutions by making a thermoreversible gel from a solution of polyketone and a solvent for the polymer having a boiling temperature above 443 K, a melting temperature below 373 K, and a polymer disso |
| 5817857 |
(4-Hydroxy-alkylphenyl diphenyl phosphate flame rerardants |
October 6, 1998 |
| The present invention is a process for forming monohydroxy-terminated aromatic oligomeric phosphates by the reaction of a diaryl halophosphate, such as diphenyl chlorophosphate, optionally in the presence of some monoaryl dihalophosphate, with an aromatic diol, such as resorcinol, to |
| 5817801 |
Cellulose solutions and products made therefrom |
October 6, 1998 |
| An optically anisotropic solution containing cellulose and inorganic acids of phosphorus contains 94-100 wt % of the following constituents: cellulose; phosphoric acid and/or its anhydrides; and water; and 0-6 wt % of other constituents. This solution can be prepared in an apparatus in |
| 5814320 |
Eimeria tenella polypeptide and vaccine containing same |
September 29, 1998 |
| The invention is concerned with a protein having the immunological properties of Eimeria tenella which is reactive with a monoclonal antibody E. TEN 11P-2 raised against E. tenella sporozoites.The invention also relates to polypeptide fragments of this protein which can be used for immun |
| 5814275 |
Obstruction detector for a fluid flow line of a medical laboratory instrument |
September 29, 1998 |
| An apparatus for detecting obstructions of a flow line. A detector housing is provided having a cavity therein. The detector housing has first and second openings into the cavity. The flow line is attached to the detector housing establishing a flow path through the first opening, the ca |
| 5811103 |
Hog cholera virus vaccine and diagnostic |
September 22, 1998 |
| The present invention is concerned with a hog cholera virus vaccine comprising a polypeptide characteristic of hog cholera virus. Vector vaccines capable to express a nucleic acid sequence encoding such a polypeptide also form part of the present invention. Said polypeptide and nucle |
| 5808110 |
Cyclic ketone peroxide formulations |
September 15, 1998 |
| A transportable, storage stable cyclic ketone peroxide composition which comprises 1.0-90% by weight of one or more cyclic ketone peroxides and 10-99% by weight of one or more diluents selected from the group consisting of liquid phlegmatizers for the cyclic ketone peroxides, plastic |
| 5807534 |
In vivo binding pair pretargeting |
September 15, 1998 |
| A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a |
| 5804199 |
Oil-based and water-based adjuvant mixture |
September 8, 1998 |
| The invention relates to a vaccine comprising an antigenic substance and a mixture of two adjuvants wherein one adjuvant is oil-based whereas the other adjuvant is water-based. |
| 5804120 |
Process for making cellulose extrudates |
September 8, 1998 |
| Celluloe extrudates can be made from an optically anisotropic solution containing 94-100 wt % of: cellulose; phosphoric acid and/or its anhydrides; and water by extruding the solution, coagulating the formed extrudates, and then aftertreating those extrudates so that they have a degr |
| 5795773 |
Device for detecting microorganisms |
August 18, 1998 |
| A method and a sealable, sterilizable vessel for detecting the presence of microorganisms in a specimen, the vessel containing a liquid culture medium and a sensor with an indicator medium therein. A gas permeable membrane with a gas impermeable removable seal thereon are provided in a |
| 5795741 |
Coccidiosis poultry vaccine |
August 18, 1998 |
| This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used fo |
| 5792644 |
DNA encoding an Eimeria 200 kd antigen |
August 11, 1998 |
| The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be |
| 5789528 |
Process for the preparation of polyesters and copolyesters |
August 4, 1998 |
| The preparation of polyesters and copolyesters, titanium dioxide precipitates and/or titanium dioxide/silicon dioxide coprecipitates having a composition of TiO.sub.2 :SiO.sub.2 >90:10 mol/mol and/or titanium dioxide/zirconium dioxide coprecipitates having a composition of TiO.sub.2 |
| 5789388 |
Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
August 4, 1998 |
| The present invention relates to a vaccine against a virus associated with antibody-dependent-enhancement of viral infectivity. Such a vaccine comprises a herpesvirus vector which is able to spread from cell-to-cell and which does produce non-infectious progeny virions having a gene |
| 5789233 |
DNA encoding an Eimekia 50 KD antigen |
August 4, 1998 |
| The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be |
| 5787901 |
Method for the measurement of blood coagulation properties with absorbent materials |
August 4, 1998 |
| A point-of-care device allows for a simple and rapid determination of blood coagulation properties. The device is comprised of an absorbent material and a clotting agent. In operation, a quantity of blood is first allowed to clot, after which remaining serum is allowed to migrate through |
| 5783730 |
Formation of styrene phosphonic acid |
July 21, 1998 |
| Styrene phosphonic acid (SPA) can be formed the reaction of phosphorous acid with acetophenone, preferably in the presence of a Lewis acid catalyst, to form a hydroxy adduct intermediate thereof which is then reacted with acetic anhydride to form the acyl derivative of the hydroxy ad |
| 5783197 |
Eimeria polypeptide antigen and vaccines containing the same |
July 21, 1998 |
| The present invention is concerned with a polypeptide of Eimeria which can be used for the immunization of poultry against coccidiosis. Furthermore, the invention comprises a DNA fragment of Eimeria coding for said polypeptide. |
| 5783192 |
Recombinant feline herpesvirus vaccine |
July 21, 1998 |
| The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome.The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived f |
| 5780298 |
DNA encoding the sn-RNP-A antigen and fragments thereof |
July 14, 1998 |
| The present invention relates to a DNA encoding the human U.sub.1 -snRNP-A protein antigen, wherein said protein antigen is reactive towards an auto-antibody which is associated with an auto-immune disease, and the use of this protein in diagnostic tests relating to auto-immune diseases. |
| 5780289 |
Coccidiosis poultry vaccine DNA encoding an elmeria 20K antigen |
July 14, 1998 |
| The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be |
| 5779834 |
Process of making a shoe with a spray-molded sole and shoe manufactured therefrom |
July 14, 1998 |
| A process of making a shoe includes bonding a flat structure to an upper layer of the shoe to form a bonded structure. The flat structure has a melting temperature T.sub.2 and provides stability to a shape of the upper layer. The bonded structure is positioned into a mold so that an unde |
| 5779815 |
Process for removal of lumen fillers and other soluble residues from hollow filaments |
July 14, 1998 |
| A process and an apparatus for removal of a lumen filler and/or other soluble residues from hollow filament bundles are described. The hollow filament bundles are first roughly cleaned by centrifuging, after which in a process preferably containing multiple steps they are cleaned by |
| 5777143 |
Hydrocarbon soluble alkylaluminoxane compositions formed by use of non-hydrolytic means |
July 7, 1998 |
| A hydrocarbon-soluble alkylaluminoxane composition, such as, methylaluminoxane or even a modified methylaluminoxane, can be prepared by preparing an alkylaluminoxane precursor via non-hydrolytic means, such as, by treating at least one trialkylaluminum compound with a compound contai |
| 5777090 |
Carboxymethyl inulin |
July 7, 1998 |
| Disclosed is carboxymethyl inulin having a degree of substitution (DS) ranging from 0,15 to 2,5, preferably from 0,5 to 1,5, a process for the preparation of said carboxymethyl inulin by reacting inulin at a concentration of at least 100 g/l, preferably at least 200 g/l, at elevated |
| 5776375 |
Electro-optical device stable in the 600-1600 nanometer wavelength range |
July 7, 1998 |
| The present invention provides an electro-optical device comprising NLO polymer in the active layer with improved stability for light in the wavelength range of 600-1600 nm is guided through the device. The present invention is directed to an electro-optical device comprising two claddin |
| 5776354 |
Use of a porous, particulate material in a packed filter bed for liquid/gas and/or liquid/liquid |
July 7, 1998 |
| A method for the use of a porous, preferably dimensionally stable, particulate material in a packed filter bed for separating a disperse liquid phase from a gas and/or separating a disperse liquid phase from a liquid, with the average size of the particles being in the range of from |
| 5773605 |
Sulfated glycosaminoglycanoid derivatives of the heparin sulfate type |
June 30, 1998 |
| The invention relates to sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type, of which N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, or O-sulfate groups. The compounds have antithrombotic and smooth muscle cell prol |
| 5770360 |
Elimination of false negatives in nucleic acid detection |
June 23, 1998 |
| The present invention relates to a method for the elimination of false negative test results in assays for the detection of amplified analyte nucleic acid in a sample. Prior to amplification, an internal control is added to the sample, comprising a nucleic acid distinguishable from the |
| 5766908 |
High-flux semipermeable membrane containing immobilized affinity ligands |
June 16, 1998 |
| An affinity support is provided containing a high flux semipermeable hydrogel membrane surface-modified with an affinity ligand, such as a protein which may be an antibody or enzyme, or a cell receptor complement, useful for affinity separation of biological macromolecules, including |
| 5766844 |
Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
June 16, 1998 |
| A novel cell line chronically infected with HIV-2.sub.NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100 |
| 5764820 |
Method of forming integrated electro-optical device containing polymeric waveguide and semicondu |
June 9, 1998 |
| The invention relates to a method of fabricating an electro-optical device which comprises integrating a semiconductor component with a polymeric optical waveguide component. According to the invention, a semiconductor component obtained by epitaxial lift-off (ELO) is embedded in a waveg |
| 5760859 |
Retardation layer having a dispersion adapted to the active liquid-crystalline cell |
June 2, 1998 |
| The invention is in the field of retardation layers comprising high-molecular weight liquid-crystalline material for liquid-crystalline displays. The invention is directed to a retardation layer for a liquid-crystalline display comprising high-molecular weight liquid-crystalline mate |
| 5760315 |
Sample collection device with assay reagent and barrier |
June 2, 1998 |
| A sample collection device is described which comprises an absorbing material which can readily absorb and release test liquid, and which additionally comprises at least one assay reagent. The assay reagent is present in only part of the absorbing material, the remaining part of the |
| 5760199 |
Polysaccharide acid amide comprising fatty alkyl group in amide |
June 2, 1998 |
| Polysaccharide acid amide compositions are disclosed which contains one extra carbon atom as compared to the polysaccharide and which comprises an acid amide of the formula --C(O)N(R)(R') where R is selected from the group consisting of hydrogen and alkyl of from about one to about four |
| 5759858 |
Calibrator and use thereof in an immunoassay |
June 2, 1998 |
| The invention relates to a composition comprising among others a fibrinopeptide A releasing compound. Furthermore the invention relates to the use of the composition as calibrator in plasma containing fibrinogen. A test kit comprising the said composition and a method to determine so |
| 5759348 |
Aromatic polyamide pulp and its production process |
June 2, 1998 |
| The aromatic polyamide pulp obtained by the process of this invention is good in dispersibility in water and good in opening property, and excellent in dispersibility of inorganic filler and wettability with and adhesion to a matrix resin such as phenol resin. Hence, an impregnated p |
| 5756618 |
Polyol(allyl carbonate) compositions containing epoxy for reduced shrinkage |
May 26, 1998 |
| The present invention relates to a polyol(allyl carbonate) based casting composition suitable for forming high quality ophthalmic lenses which contains an epoxy compound in an amount effective to reduce shrinkage during its final polymerization in a mold. The casting composition of the |
| 5753457 |
Quantification of active plasminogen-activator-inhibitor-type-1 |
May 19, 1998 |
| A method for the quantification of active plasminogen-activator-inhibitor-type-1 (PAI-type-1) presence in a sample, a method for preparing a reference curve for use in the quantification, a kit for carrying out the method for quantification and a carrier such as a microtiter plate co |
| 5750756 |
Process for the formation of hydrocarbyl bis(hydrocarbyl phosphate) |
May 12, 1998 |
| A process for forming a composition containing over, for example, about 90% by weight of an alkylene-arylene bridging group-containing bis(diphenyl phosphate) compound and less than, for example, 10%, by weight, of monophosphate by-product. This process involves the reaction of a com |
| 5750115 |
Escherichia coli vaccine |
May 12, 1998 |
| According to the present invention it has been found that a novel E. coli toxin or an immunogenic fragment thereof can be used in the preparation of vaccines for warm-blooded animals, and in particular for birds. Said toxin is found to be associated in flagellar structures attached to th |
| 5750113 |
Poultry vaccine |
May 12, 1998 |
| This invention relates to a novel infectious bronchitis virus (IBV) serotype and to attenuated IBV strains derived therefrom, and also to live or inactivated vaccines made using such IB virus. |
